Geilenkirchen, Germany

Dieter Peschen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2009.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dieter Peschen: Innovator in Plant Disease Resistance

Introduction

Dieter Peschen is a notable inventor based in Geilenkirchen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for enhancing plant disease resistance.

Latest Patents

Dieter Peschen holds a patent for "Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi." This patent outlines a method for producing fungus-resistant transgenic plants, plant cells, or plant tissue. The process involves introducing specific antibodies or vectors into the genome of a plant, thereby creating a transgenic plant cell that integrates a polynucleotide or vector for enhanced disease resistance.

Career Highlights

Peschen is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading organization in applied research. His work focuses on innovative solutions to combat plant diseases, which is crucial for agricultural sustainability.

Collaborations

Throughout his career, Dieter has collaborated with esteemed colleagues such as Yu-Cai Liao and Stefan Schillberg. These partnerships have furthered research in plant biotechnology and disease resistance.

Conclusion

Dieter Peschen's contributions to plant disease resistance through innovative patenting and collaboration highlight his role as a key figure in biotechnology. His work continues to impact agricultural practices and enhance food security.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…